thrombosis
AML, acute myeloid leukemia; MDS, myelodysplastic syndrome.
Platelets circulate along the vessel wall and act to stop bleeding at sites of vessel injury. This hemostatic process requires multiple ligand-receptor interactions to tether, activate, and aggregate platelets. The tightly controlled platelet activation and aggregation that occurs at the site of vascular injury during hemostasis can become dysregulated in pathological conditions, promoting thrombosis and inflammation. For example, platelets promote arterial thrombosis or thromboembolism when activated either on the surface of a ruptured atherosclerotic plaque or by pathological levels of high fluid shear stress in the area of arterial stenosis, leading to acute thrombotic events such as ischemic stroke and myocardial infarction ( 11 ). Emerging evidence further suggests that platelets also act as a cellular mediator in a variety of pathophysiological conditions such as cancer, rheumatoid arthritis, atherosclerosis, trauma, and immune response ( 12 – 14 ). How transcription factors regulate platelet production from megakaryocytes has been extensively reported, but their non-transcriptional activities (i.e., activity independent of gene regulations) have only begun to be recognized. Here, we discuss several transcription factors that have been reported to regulate platelet production and function.
2.1. runt-related transcription factor 1.
In 1969, Weiss, et al. identified a family with an autosomal dominant inherited thrombocytopenia, caused primarily by decreased dense granule contents ( 15 ). A heterozygous Y260X mutation in the RUNX1 gene was subsequently shown to be the genetic basis of this inherited platelet defect ( 15 , 16 ). To date, more than 200 families with RUNX1 variants have been reported ( 17 ). RUNX1/AML1 (also known as CBFA2 and PEBP2αB) is a member of the Runt family, which has three known transcription factors (RUNX1, RUNX2, and RUNX3), which share the Runt homology domain near the N-terminus. This domain interacts with CBFb to bind specific sequences of DNA to regulate its transcription ( 18 ).
RUNX1 regulates several genes that control platelet production, structure, function, and intracellular signaling. One report found that 22 patients in a family with autosomal dominant thrombocytopenia had mutations in the RUNX1 gene ( 19 ) and 6 of them developed hematologic malignancies ( 20 ). RUNX1-deficient mice die in uterus due to defective hematopoiesis and resultant severe bleeding ( 21 , 22 ). Mice with the conditional knockout survive but have an impaired megakaryocyte maturation with a significant reduction in megakaryocyte polyploidization ( 23 ). Variations in the RUNX1 gene often result in bleeding diathesis, primarily because of defective platelet granules ( 15 , 16 ), which reduce platelet activation and aggregation ( 24 ). For example, mice carrying the RUNX1 p.Leu43Ser variant (equivalent to human p.Leu56Ser) exhibit a prolonged bleeding time because of defective α-granule secretion and platelet spreading ( 25 ). RUNX1 deficiency can result in pallidin dysregulation and deficient dense granules in platelets ( 26 ) as well as the Ras-related protein RAB31-mediated early endosomal trafficking of von Willebrand factor (VWF) and epidermal growth factor receptor (EGFR) in megakaryocytes ( 27 ). RUNX1 regulates the development of platelet granules through interaction with genes involved in the biogenesis of platelet granules such as the nuclear factor erythroid 2 (NF-E2).
In addition, RUNX1 can also regulate genes related to platelet functions. For example, it regulates the transcription of the non-muscle myosin IIA (MYH9) and IIB (MYH10) genes, which encode non-muscle myosin II heavy chains; RUNX1 mutations are associated with dysregulated expression of MYH10 in platelets ( 28 ); and the expression level of non-muscle myosin is used as a marker for changes in transcriptional activity of RUNX1 as well as friend leukemia integration 1 transcription factor (FLI1) ( 29 ). RUNX1 also regulates the expression of the arachidonate 12-lipoxygenase gene (ALOX12) ( 30 ), which encodes the enzyme that acts on polyunsaturated fatty acid substrates to generate bioactive lipid mediators to regulate platelet function ( 30 ). PCTP (phosphatidylcholine transfer protein) regulates the intermembrane transfer of phosphatidylcholine and its upregulation by RUNX1 sensitizes platelet response to thrombin through protease-activated receptor 4 ( 31 ). RUNX1 also regulates the expression of platelet factor 4 through coordination with transcription factors in the ETS family that share a conserved winged helix-turn-helix DNA binding domain that recognizes unique DNA sequences containing GGAA/T ( 32 ). Platelet factor 4 belongs to the CXC chemokine family and is released from α-granules of activated platelets to promote coagulation and to participate in heparin-induced thrombocytopenia ( 33 , 34 ). A recent report shows that RUNX-1 haploinsufficiency inhibits the differentiation of hematopoietic progenitor cells (HPCs) into megakaryocytes ( 35 ).
GATA-binding protein 1 (GATA1) is a transcription factor that contains two zinc finger domains: a C-terminal zinc finger that binds the (T/A) GATA(A/G) motif of DNA and an N-terminal zinc finger that is required for stabilizing the C-terminal structure and also interacts with a nuclear co-factor protein called friend for GATA1 (FOG1), which stabilizes GATA1 binding ( 36 , 37 ). GATA plays a pivotal role in hematopoietic development and is found in megakaryocytes ( 38 ). GATA1-deficient mice die before birth at approximately embryonic day 10, primarily because of severe anemia ( 39 ). However, mutations in the N-terminal zinc finger domain, which reduces the transcriptional activation of GATA1 ( 36 , 40 ), are found in patients with myeloproliferative disorders and acute megakaryoblastic leukemia ( 41 ), suggesting that GATA1-FOG1 interaction is essential for the development and maturation of megakaryocytes, the parental cells of platelets. Decreased GATA-1 expression has also been reported in patients with myelodysplastic syndrome ( 42 ).
Embryonic stem cells from GATA1-deficient mice are smaller and show low expression of megakaryocytic markers, but have a high rate of proliferation ( 43 ). Complementation of these cells with a wild-type GATA1 gene allows megakaryocytes and erythrocytes to develop in response to a variety of cytokines. Additionally, cell division is attenuated in the megakaryocytic progenitor G1ME cells that overexpress GATA1. A recent report further shows that impaired MYH10 silencing causes GATA1-related polyploidization defect during megakaryocyte differentiation ( 44 ).
Furthermore, platelet aggregation induced by collagen is inhibited in GATA1 - deficient mice ( 45 ), primarily due to reduced expression of the collagen receptor GPVI. Platelet adhesion and aggregation induced by shear stress are also reduced in GATA1 - deficient mice ( 45 ). How a GATA1 deficiency causes these changes in platelet reactivity remains unknown, but these phenotypic changes in the mice provide the first indication that transcription factors could perform non-transcriptional activities in anucleated platelets.
3.1. signal transducer and activator of transcription 3.
STAT includes a family of transcription factors critical for inflammatory and acute-phase reactions ( 46 , 47 ). They also play vital roles in cancer development and hematopoiesis ( 48 ). The homologous STAT1, STAT3, and STAT5 are expressed in human platelets and are reported to regulate platelet reactivity through residual or mitochondrial transcriptional activity in platelets. For example, STAT3 affects mitochondrial transcription by binding to the regulatory D-loop region of mitochondrial DNA upon platelet activation ( 49 ).
However, STAT3 can also be activated (phosphorylated) and dimerized in platelets stimulated with thrombopoietin ( 49 , 50 ), suggesting that STAT3 can also regulate platelet reactivity through non-transcriptional means. We have shown that STAT3 is activated and dimerized in collagen-stimulated platelets to serve as a protein scaffold that facilitates the catalytic interaction between spleen tyrosine kinase (Syk) and its substrate, PLCγ to enhance collagen-induced calcium mobilization and platelet activation ( 8 ). More importantly, STAT3 is activated to form dimers by a complex of IL-6 with its soluble receptor IL-6Rα, which activates JAK2 ( 51 ). The pharmacological inhibition of platelet STAT3 reduces collagen-induced platelet aggregation and thrombus formation on the collagen matrix ( 8 , 52 ). Platelets from STAT3-deficient mice or mice infused with a STAT3 inhibitor have reduced collagen-induced aggregation. This non-transcriptional activity of STAT3 may be critical for the development of platelet hyper-reactivity, which has been widely associated with inflammation, especially that related to the activity of the proinflammatory cytokine IL-6 ( 8 ). We have also shown that the piper longum derivative piperlongumine (PL) blocks collagen-induced platelet reactivity in a dose-dependent manner by targeting STAT3 ( 53 ). Consistent with our observations, the small molecular STAT3 inhibitor SC99 has been shown to reduce platelet activation and aggregation induced by collagen and thrombin ( 54 ). These findings offer a new pathway for reducing platelet hyper-reactivity in conditions of inflammation and in prothrombotic states associated with trauma, cancer, autoimmune diseases, and severe infection.
Nuclear factor kappa β (NFκB) is a well-defined redox-sensitive transcription factor that regulates the immune response and inflammation by controlling the expression of multiple genes activated by inflammatory mediators ( 55 – 57 ). Blocking NFκB can therefore improve outcomes of inflammatory diseases ( 58 ). NFκB is composed of p50 and p65 subunits, normally as an inactive cytoplasmic complex. The inhibitory proteins of the IκB family tightly bind the subunits of NFκB ( 59 ). Upon activation, the IκK complex phosphorylates IκBα, thus activating NFκB by detaching it from IkBα ( 60 – 62 ). Three IκK family members, α, β, and γ, are expressed in platelets, with β being the most abundant, and are reported to regulate platelet reactivity through non-transcriptional activity ( 9 , 10 , 63 ). For example, the pharmacological inhibition of IκKβ leads to reduced agonist-induced platelet activation, increased bleeding time, and prolonged thrombus formation in a mouse model ( 64 ). NF-κB has also been reported to be partially involved in the regulation of SERCA activity to regulate calcium homeostasis in platelets ( 65 ). IκKβ-deficient platelets lose the ability to shed the ectodomain of GP Ibα in response to ADP or collagen stimulations ( 66 ) but preserve thrombin-induced GP Ibα shedding ( 67 ). Collagen-induced p65 and IκKβ phosphorylation is blocked by inhibition of MAP kinase, but not by inhibition of ERK in platelets ( 68 ). The thrombin-induced GP Ibα shedding requires p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK) as its upstream and downstream molecules ( 68 , 69 ).
The peroxisome proliferator-activated receptors (PPARs) are ligand-activated receptors in the nuclear hormone receptor family. They contain three subtypes (PPARα, PPARβ/δ, and PPARγ), which are essential in the regulation of cell differentiation, development, and metabolism ( 70 – 72 ). All PPARs heterodimerize with retinoid X receptor (RXR) and subsequently bind to a specific region of target genes called a peroxisome proliferator response element (PPRE) ( 73 ). PPARγ plays a transcription factor role in regulating platelet production from megakaryocytes, but the PPARγ ligand thiazolidinedione inhibits platelet aggregation induced by ADP under hydrostatic pressure and in diabetic mice ( 74 – 76 ). Similarly, activating PPARβ/δ also reduces platelet reactivity to ADP, thrombin, and collagen ( 77 , 78 ). However, PPARα is also required for platelet activation and thrombus formation, in which it regulates the dense granule secretion of platelets in hyperlipidemic mice ( 79 ). The reason for this apparent contradiction remains to be further investigated. PPARγ is recruited and phosphorylated by Syk to promote the recruitment of the protein called Linker for the Activation of T cells (LAT), which is necessary for collagen-induced platelet activation through glycoprotein VI ( 80 ).
While transcription factors are critically involved in megakaryocyte development and platelet production, they may also regulate platelet reactivity to conventional and specific platelet agonists ( Figure 1 ). The latter is independent of transcriptional activity, for which it is present but at a residual level. This non-transcriptional activity remains poorly understood and requires further investigation because it helps understanding how platelets are activated either by conventional agonists for hemostasis or as complications found in patients treated with drugs that block transcriptional activity of cells (e.g., cancer treatments). Such research will also play an important role in developing new therapeutics targeting these transcription factors to enhance or reduce platelet reactivity.
Transcription factors regulate platelet aggregation through non-transcriptional activities. (A) PPARγ is recruited and phosphorylated by Syk to promote the recruitment of LAT and enhance platelet aggregation; (B) NFκB is activated by upstream p38 mitogen-activated protein kinase (MAPK) and promotes platelet aggregation by regulating downstream extracellular signal-regulated kinase (ERK); (C) A complex of IL-6 with its soluble receptor IL-6R activates JAK2 to phosphorylate and dimerize STAT3, then the activated STAT3 serves as a protein scaffold to facilitate the catalytic interaction between the spleen tyrosine kinase (Syk) and its substrate PLCγ2 to promote platelet aggregation.
Extracellular vesicles (EVs) are shed membrane fragments, intracellular organelles, and nuclear components from cells undergoing active microvesiculation ( 81 – 84 ) or apoptosis ( 85 – 87 ). The former is triggered by the activation of the cysteine protease calpain, which disrupts the membrane-cytoskeleton association ( 88 – 91 ). Platelets are the primary source of EVs circulating in blood, accounting for approximately 80% of total EVs ( 92 – 94 ). The subcellular size of EVs allows them to travel to areas where parental cells are unable to go. In additional to inherent functions from their parental cells, EVs also perform unique activities of their own because of molecules expressed on their surface and carried by them, the latter of which include transcription factors such as STAT3, STAT5, and PPARγ ( 95 ) as well as regulators of transcription factors ( 96 , 97 ). This EV-derived transcriptional activity has been scarcely reported but hold greats potential for influencing biological activities of target cells. For example, PPARγ in platelet EVs is taken up by monocytic THP-1 cells, where it induces the expression of fatty acid-binding protein-4 (FABP4). Monocytes receiving PPARγ-containing platelet EVs produce less inflammatory mediators and become more adherent through increased fibronectin production ( 95 ). Although reports on platelet-derived transcription factors remain very limited, a large body of evidence in the literature shows that platelet-derived EVs, especially EV-carried microRNAs, can change transcriptional activities, thus regulating the function of target cells. Platelet EV-carried NLR family pyrin domain containing 3 (NLRP3) stimulates endothelial cells to undergo pyroptosis through the NLRP3/nuclear factor (NF)-κB pathway ( 98 ). EVs from platelets stimulated with bacteria provoke proinflammatory activity of monocytes through the TRAF6/NFκB pathway ( 99 ). MicroRNA-142-3p carried by platelet-derived EVs promotes the proliferation of endothelial cells ( 100 ), whereas microRNA-126-3p-carrying platelet EVs can be internalized by macrophages to dose-dependently downregulate expression of target mRNA ( 101 ). These observations mostly pertain to phenotypic characterization with less information regarding the underlying pathways involved. Systemic studies of EV-carrying transcription factors and related mediators are therefore urgently needed.
Platelets lack a nucleus and de novo transcription, but a number of transcription factors are found in platelets and may have non-transcriptional activities that regulate platelet function. Transferring transcription factors between platelets and target cells through platelet EVs could also be a novel regulatory mechanism of cell-cell communications and a potential therapeutic target for a variety of pathologies.
HY and YL performed the literature search and compiled all the information from the researched articles and wrote the manuscript. ZZ, J-FD and JZ formulated, proposed, guided and wrote the manuscript. All authors contributed to the article and approved the submitted version.
This study is supported by Young Scientists Award 82022020 from the National Natural Science Foundation of China (ZZ), National Natural Science Foundation of China 81971176 (ZZ), 81271361, 81271359 (JZ), 81102447 (HY), National Natural Science Foundation of China State Key Program Grant 81330029, National Natural Science Foundation of China Major International Joint Research Project 81720108015 (JZ), and Postdoctoral Science Foundation of China Grants 2013M541190 (HY).
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Advertisement
Z. Liu, Y. Hu, H. Xie, and K. Chen contributed equally to this article.
Cancer Discov 2024;14:1082–105
Zhenyu Liu , Yuqiong Hu , Haoling Xie , Kexuan Chen , Lu Wen , Wei Fu , Xin Zhou , Fuchou Tang; Single-Cell Chromatin Accessibility Analysis Reveals the Epigenetic Basis and Signature Transcription Factors for the Molecular Subtypes of Colorectal Cancers. Cancer Discov 1 June 2024; 14 (6): 1082–1105. https://doi.org/10.1158/2159-8290.CD-23-1445
Download citation file:
Colorectal cancer is a highly heterogeneous disease, with well-characterized subtypes based on genome, DNA methylome, and transcriptome signatures. To chart the epigenetic landscape of colorectal cancers, we generated a high-quality single-cell chromatin accessibility atlas of epithelial cells for 29 patients. Abnormal chromatin states acquired in adenomas were largely retained in colorectal cancers, which were tightly accompanied by opposite changes of DNA methylation. Unsupervised analysis on malignant cells revealed two epigenetic subtypes, exactly matching the iCMS classification, and key iCMS-specific transcription factors (TFs) were identified, including HNF4A and PPARA for iCMS2 tumors and FOXA3 and MAFK for iCMS3 tumors. Notably, subtype-specific TFs bind to distinct target gene sets and contribute to both interpatient similarities and diversities for both chromatin accessibilities and RNA expressions. Moreover, we identified CpG-island methylator phenotypes and pinpointed chromatin state signatures and TF regulators for the CIMP-high subtype. Our work systematically revealed the epigenetic basis of the well-known iCMS and CIMP classifications of colorectal cancers.
Our work revealed the epigenetic basis of the well-known iCMS and CIMP classifications of colorectal cancers. Moreover, interpatient minor similarities and major diversities of chromatin accessibility signatures of TF target genes can faithfully explain the corresponding interpatient minor similarities and major diversities of RNA expression signatures of colorectal cancers, respectively.
This article is featured in Selected Articles from This Issue, p. 897
Citing articles via, email alerts.
Sign In or Create an Account
Shaoliang Mou, Weihong He, Haitao Jiang, Qianqian Meng, Tingting Zhang, Zhiqin Liu, Ailian Qiu, Shuilin He, Transcription factor CaHDZ15 promotes pepper basal thermotolerance by activating HEAT SHOCK FACTORA6a , Plant Physiology , Volume 195, Issue 1, May 2024, Pages 812–831, https://doi.org/10.1093/plphys/kiae037
High temperature stress (HTS) is a serious threat to plant growth and development and to crop production in the context of global warming, and plant response to HTS is largely regulated at the transcriptional level by the actions of various transcription factors (TFs). However, whether and how homeodomain-leucine zipper (HD-Zip) TFs are involved in thermotolerance are unclear. Herein, we functionally characterized a pepper ( Capsicum annuum ) HD-Zip I TF CaHDZ15. CaHDZ15 expression was upregulated by HTS and abscisic acid in basal thermotolerance via loss- and gain-of-function assays by virus-induced gene silencing in pepper and overexpression in Nicotiana benthamiana plants. CaHDZ15 acted positively in pepper basal thermotolerance by directly targeting and activating HEAT SHOCK FACTORA6a ( HSFA6a ), which further activated CaHSFA2 . In addition, CaHDZ15 interacted with HEAT SHOCK PROTEIN 70-2 (CaHsp70-2) and glyceraldehyde-3-phosphate dehydrogenase1 (CaGAPC1), both of which positively affected pepper thermotolerance. CaHsp70-2 and CaGAPC1 promoted CaHDZ15 binding to the promoter of CaHSFA6a , thus enhancing its transcription. Furthermore, CaHDZ15 and CaGAPC1 were protected from 26S proteasome-mediated degradation by CaHsp70-2 via physical interaction. These results collectively indicate that CaHDZ15, modulated by the interacting partners CaGAPC1 and CaHsp70-2, promotes basal thermotolerance by directly activating the transcript of CaHSFA6a . Thus, a molecular linkage is established among CaHsp70-2, CaGAPC1, and CaHDZ15 to transcriptionally modulate CaHSFA6a in pepper thermotolerance.
Personal account.
Sign in with a library card.
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society member access to a journal is achieved in one of the following ways:
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
If you do not have a society account or have forgotten your username or password, please contact your society.
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Click the account icon in the top right to:
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.
To purchase short-term access, please sign in to your personal account above.
Don't already have a personal account? Register
Month: | Total Views: |
---|---|
January 2024 | 141 |
February 2024 | 158 |
March 2024 | 185 |
April 2024 | 67 |
May 2024 | 74 |
June 2024 | 39 |
Citing articles via.
Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide
Sign In or Create an Account
This PDF is available to Subscribers Only
For full access to this pdf, sign in to an existing account, or purchase an annual subscription.
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess .
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
Find support for a specific problem in the support section of our website.
Please let us know what you think of our products and services.
Visit our dedicated information section to learn more about MDPI.
Interaction of the transcription factors bes1/bzr1 in plant growth and stress response.
2. interactors of bes1/bzr1 in plant growth and development, 2.1. interactors of bes1/bzr1 in skotomorphogenesis and photomorphogenesis, 2.2. interactors of bes1/bzr1 in root growth, 2.3. interactors of bes1/bzr1 in other developmental processes, 3. interactors of bes1/bzr1 in stress response, 3.1. interactors of bes1/bzr1 in abiotic stress response, 3.2. interactors of bes1/bzr1 in biotic stress response, 4. conclusions, author contributions, institutional review board statement, informed consent statement, data availability statement, conflicts of interest.
Click here to enlarge figure
Gene Name | Locus | Effect on Plant Growth through Interaction with BES1/BZR1 | References |
---|---|---|---|
ARF6 | AT1G30330 | Promoting cell elongation and hypocotyl growth | [ ] |
PIF4 | AT2G43010 | Promoting cell elongation and hypocotyl growth | [ ] |
BIC1 | AT3G52740 | Promoting cell and hypocotyl elongation | [ ] |
BLI | AT3G23980 | Promoting hypocotyl elongation in darkness | [ ] |
RGA | AT2G01570 | Inhibiting cell elongation and BR-regulated plant growth | [ ] |
HSP90 | AT5G52640 | Promoting hypocotyl elongation | [ ] |
EIN3 | AT3G20770 | Promoting apical hook development | [ ] |
SAUR17 | AT4G09530 | Promoting apical hook and closed cotyledon | [ ] |
WAG2 | AT3G14370 | Inhibiting apical hook development | [ ] |
GRF7 | AT5G53660 | Repressing chlorophyll biosynthesis promoting cell elongation | [ ] |
phyB | AT2G18790 | Repressing BR signaling | [ ] |
CRY1 | AT4G08920 | Inhibiting hypocotyl elongation under blue light | [ , ] |
UVR8 | AT5G63860 | Repressing BR-regulated photomorphogenesis | [ ] |
BBX32 | AT3G21150 | Inhibiting cotyledon opening | [ ] |
SHR | AT4G37650 | Suppressing root lignification promoting periclinal division | [ , ] |
BRAVO | AT5G17800 | Suppressing root quiescent center division | [ ] |
AGB1 | AT4G34460 | Promoting cell elongation | [ ] |
PKL | AT2G25170 | Promoting cell elongation | [ ] |
C3H15 | AT1G68200 | Inhibiting cell elongation | [ ] |
CYP20-2 | AT5G13120 | Promoting flowering | [ ] |
ACO1 | AT2G19590 | Promoting fruit ripening | [ ] |
OsWRKY53 | Os05g0343400 | Regulating rice architecture and increasing seed size | [ , ] |
OsMED25 | Os09g0306700 | Regulating rice architecture | [ ] |
Gene Name | Locus | Effect on Stress Tolerance through Interaction with BES1/BZR1 | References |
---|---|---|---|
WRKY46 | AT2G46400 | Suppressing drought response | [ ] |
WRKY54 | AT2G40750 | Suppressing drought response | |
WRKY70 | AT3G56400 | Suppressing drought response | |
RD26 | AT4G27410 | Inhibiting BR-regulated growth under drought condition | [ ] |
TINY | AT5G25810 | Inhibiting BR-regulated growth under drought condition | [ ] |
HSFA1a | AT4G17750 | Improving heat stress | [ ] |
LBD37 | AT5G67420 | Promoting nitrogen response | [ ] |
OsIDD10 | Os04g47860 | Improving nitrogen uptake | [ ] |
phyB | AT2G18790 | Inhibiting nitrogen uptake and sheath blight resistance | [ , ] |
MYB34 | AT5G60890 | Suppressing insect defense | [ ] |
MYB122 | AT1G74080 | Suppressing insect defense | [ ] |
MYB51 | AT1G18570 | Suppressing insect defense | [ ] |
EDS1 | AT3G48090 | Increasing pathogen resistance | [ ] |
GhTINY2 | GhD06G0642 | Increased immune response | [ ] |
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
Cao, X.; Wei, Y.; Shen, B.; Liu, L.; Mao, J. Interaction of the Transcription Factors BES1/BZR1 in Plant Growth and Stress Response. Int. J. Mol. Sci. 2024 , 25 , 6836. https://doi.org/10.3390/ijms25136836
Cao X, Wei Y, Shen B, Liu L, Mao J. Interaction of the Transcription Factors BES1/BZR1 in Plant Growth and Stress Response. International Journal of Molecular Sciences . 2024; 25(13):6836. https://doi.org/10.3390/ijms25136836
Cao, Xuehua, Yanni Wei, Biaodi Shen, Linchuan Liu, and Juan Mao. 2024. "Interaction of the Transcription Factors BES1/BZR1 in Plant Growth and Stress Response" International Journal of Molecular Sciences 25, no. 13: 6836. https://doi.org/10.3390/ijms25136836
Article access statistics, further information, mdpi initiatives, follow mdpi.
Subscribe to receive issue release notifications and newsletters from MDPI journals
An integrative temperature-controlled microfluidic system for budding yeast heat shock response analysis in single cell level.
Cells can respond and adapt to complex forms of environmental change. Budding yeast is wildly used as a model system for these stress response studies. In these studies, the precise control of the environment with high temporal resolution is most important. However, there is a lack of single-cell research platforms that enable precise control of the temperature and form of cell growth. This has hindered our understanding of cellular coping strategies in the face of diverse forms of temperature change. Here, we developed a novel temperature-controlled microfluidic platform that integrates a micro-heater(using liquid metal) and thermocouple(liquid metal vs conductive PDMS) on a chip. Three forms of temperature changes: step, gradient, and periodical oscillations were realized by automated equipment. The platform has the advantages of low cost and a simple fabrication process. Moreover, we investigated the nuclear entry and exit behaviors of the transcription factor Msn2 in yeast in response to heat stress (37°C) with different heating modes. The feasibility of this temperature-controlled platform for studying the protein dynamic behavior of yeast cells was demonstrated.
Download citation, permissions.
J. Hong, H. He, Y. Xu, S. Wang and C. Luo, Lab Chip , 2024, Accepted Manuscript , DOI: 10.1039/D4LC00313F
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page .
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page .
Read more about how to correctly acknowledge RSC content .
Search articles by author.
This article has not yet been cited.
Photo credit: Justin Knight
There were 57 clinician-scientists in this year’s graduating class, 40 attended the ceremony
Mindy Blodgett | IMES-HST
The 2024 graduating class of the Harvard-MIT Program in Health Sciences and Technology (HST) gathered on May 22, to celebrate their accomplishments with their families and friends, at the MIT Bartos Theater & Atrium. Also in attendance were HST alumni, faculty, and staff.
This 2024 graduation class includes 57 graduates: 35 MD graduates, and 25 Medical Engineering and Medical Physics (MEMP)PhDs; one Master of Science graduate, and one Graduate Education in Medical Sciences, or GEMS certificate, recipient. There were 40 graduates in attendance. HST MD graduates also participated in Harvard graduation events on May 23, and graduates of the HST Medical Engineering and Medical Physics (MEMP) PhD program participated in the MIT School of Engineering Advanced Degree Ceremony, and hooding event, on May 29.
All enjoyed congratulatory remarks from HST Associate Director Richard N. Mitchell, MD, PhD; Dean of the Harvard Medical School (HMS) George Q. Daley, MD (HST ’91), PhD; and Elazer Edelman, MD (HST ’83), PhD (HST ’84), Director of the Institute for Medical Engineering and Science (IMES). Also participating in the ceremony were Wolfram Goessling MD, PhD, the co-director of HST at Harvard, Collin M. Stultz, MD, (HST ’97), PhD, co-director of HST at MIT, and associate director of IMES (IMES is HST’s home at MIT), as well as Junne Kamihara, Associate Director, MD Advising, HST, and HST Associate Director, Matthew Frosch.
L to R, Junne Kamihara, Associate Director, MD Advising, HST; HST Associate Director Richard N. Mitchell, MD, PhD. Photo credit: Justin Knight
Dean Daley, an HST alumnus, called the occasion, a “spectacular achievement to graduate from the country’s pre-eminent program in translational biomedical science and engineering” and he praised the graduates’ “persistence in getting through the pandemic,” as Covid was at its height when many from the class began their studies in 2020. Daley observed that the graduates will witness “explosive developments” during their careers, in such areas as gene editing, artificial intelligence (AI) and the needs of an aging population.
Harvard Medical School (HMS) George Q. Daley, MD (HST ’91), PhD. Photo credit: Justin Knight.
Stultz called addressing the graduates “one of the best parts of my job,” remarking that “few individuals have achieved your level of accomplishments.”
Collin M. Stultz, MD, (HST ’97), PhD, co-director of HST at MIT, and associate director of IMES. Photo credit: Justin Knight.
Wolfram Goessling MD, PhD, the co-director of HST at Harvard, congratulated the graduates and their families and friends. Photo credit: Justin Knight.
Edelman, an HST alumnus, who is also a senior attending physician, Brigham and Women’s Hospital, shared a story about one of his patients, a middle school principal from Western Massachusetts, who was the “heart and soul” of his school, and of his small town. He said that the graduates were chosen for HST because “of what we saw in you…your heart and soul” and that “together, we can harness medicine to make the world a better place.”
Elazer Edelman, MD (HST ’83), PhD (HST ’84), Director of the Institute for Medical Engineering and Science (IMES). Photo credit: Justin Knight.
Abby Aymond, an HST MD graduate, was the 2024 class speaker. She praised the “exceptional sense of community and friendship” she had experienced while a student at HST. She said the some of the lessons she was taking from her years at HST were to “relax all the noise…focus only on the problem at hand…and to always be open to new information.”
Abby Aymond, HST MD graduate, was the 2024 class speaker. Photo credit: Justin Knight.
Elazer Edelman, left, and George Daley, right, address the graduates at the end of the ceremony, urging them to stay in touch. Photo credit: Justin Knight.
HST Associate Director Richard N. Mitchell donned the traditional Red Sox graduation cap, and applauded the graduates. Photo credit: Justin Knight.
The HST 2024 Graduates:
Doctor of Medicine
Medical Sciences
Abby Aymond, BS
Thesis Topic: Optimization of Ventricular Efficiency and Renal Artery Perfusion in a Bench Top Model System
Alaleh Azhir, BS
Thesis Topic: Chromosomes vs Hormones: Decoding the Expression Mosaic in Liver and Adipose Tissues
James Diao, BS
summa cum laude
The Seidman Prize for Outstanding HST Senior Medical Student Thesis
Richard C. Cabot Prize
Thesis Topic: The Use of Race in Clinical Algorithms
Christopher Michael Dietrich, BS
Thesis Topic: Towards Treat-Seq: Predicting Therapeutic Response from Transcriptomic Signatures
Jonah Issac Donnenfield, BA
magna cum laude
Thesis Topic: Transcriptomic Profiling of the Post-traumatic Porcine Knee: Degenerative Pathophysiology and Machine Learning Application
Micayla Flores, SB
Thesis Topic: Ambulatory and Delivery Obstetric Comorbidity Index (OB-CMI) for Identification of Pregnant Individuals at Risk for Severe Maternal Morbidity (SMM)
Allyson Freedy, BA, PhD
Leon Reznick Memorial Prize
HMS Multiculturalism Award
Thesis Topic: Uncovering the Biology of Chromatin Regulators with Drug Resistance Alleles
William Hao Ge, BS
Thesis Topic: Stereotypic Patterns and Genomic Correlates of Organotropism in Metastatic Melanoma
Blake Hauser, BSPH, PhD
Thesis Topic: Structure-Based Network Analysis Predicts Pathogenic Variants in Human Proteins Associated with Inherited Retinal Disease
Sofia Hu, BA, PhD
Thesis Topic: Transcription Factor Antagonism Regulates Heterogeneity in Embryonic Stem Cell States
Nauman Javed, BS, PhD
Thesis Topic: Strategies for Characterizing the Regulatory Code of the Human Genome
Tushar Vinod Kamath, SB, SM, PhD
Thesis Topic: Cell States and Neuronal Vulnerabilities in Neurodegenerative Diseases
Minjee Kim, BA
Thesis Topic: Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
Patrick Lenehan, BS, PhD
Thesis Topic: Investigating the Impact of Eosinophils on Pancreatic Cancer Growth and Metastasis
Claudio Macias Trevino, BS, PhD
Thesis Topic: Transcriptional Regulation of Esrp1 and its Role in Craniofacial Morphogenesis
Eliana Marostica, BA, MBMI
Thesis Topic: Systematic Quantification of Morphological Patterns in Surgical Specimens of Cancers
Eduardo Maury, SB, PhD
Thesis Topic: Somatic Mutations in the Human Brain: Tracing the Origins of Cancer and Schizophrenia
Elizabeth Minten, BS, PhD
Thesis Topic: Role of CDK12 in R-Loop Formation
Katherine Nabel Smith, BS, PhD
Thesis Topic: Molecular Mechanisms for Broad Neutralization of Emerging RNA Viruses
Julia E. Page, SB, PhD
Thesis Topic: Peptidoglycan Hydrolases, their Protein Partners, and Related Membrane Proteins in Staphylococcus Aureus
Deborah Plana, SB, PhD
Thesis Topic: Clinical Trial Data Science to Advance Precision Oncology
Sheridan Rea, BS, MS
Thesis Topic: Retrospective Cohort Analysis of Sociodemographic Factors and Postpartum Hemorrhage Outcomes
Sara Ann Rubin, BA, PhD
Thesis Topic: Zebrafish Immune Cell Development and Diversity in Health and Disease
Jamie Erin Shade, BS
Thesis Topic: Relationships Between Cardiac Magnetic Resonance-derived Myocardial, Hepatic, and Splenic Extracellular Volumes in Patients after the Fontan Operation
Bryce Filip Starr, BS
Thesis Topic: Generation and Validation of a Bileaflet Venous Valve for Single Ventricle Physiology
Hannah Jacqueline Szapary, BS, SM
Thesis Topic: Mechanical and Biologic Impact of Dynamic Loading on Bovine and Human Models of Osteoarthritis
Max Louis Valenstein, BS, MS, PhD
Thesis Topic: Integration of Amino Acid Signals by the mTORC1 Pathway
Sarah Weiss, SB, PhD
Thesis Topic: Deletion of an Exhaustion-specific PD-1 Enhancer Modulates CD8+ T Cell Fate and Function
Omar Yaghi, BS, PhD
Thesis Topic: Uncovering Stromal Cell Functions in Acute and Chronic Muscle Injuries
Katherine Young, SB, MEng
Thesis Topic: Transmission and Evolution of Staphylococcus Aureus in Families with Atopic Dermatitis
Doctor of Philosophy
Medical Engineering/Medical Physics
Jon Arizti Sanz, MNG
Thesis Topic: From Sample to Answer: Innovations in Sample Processing and CRISPR-based Diagnostics for Enhanced Clinical Translation and Field Deployment
Olivia Jane Arnold, SB
Thesis Topic: Therapeutic Applications of DNA Origami-based Progammable Nanoparticles
Rachel Bellisle, SB
Thesis Topic: A Wearable Countermeasure for Musculoskeletal Deconditioning in Human Spaceflight
Adam G. Berger, SB
Thesis Topic: Systematic Engineering of Controlled, Localized Oligonucleotide Delivery Systems for Wound Angiogenesis
Jennifer Dawkins, SB
Thesis Topic: Computational Prediction of Health Status from the Human Gut Microbiome and Metabolome
Brian Tshao Do, SB
Thesis Topic: Metabolic and Genetic Factors Guiding Hematopoietic Cell Fate
Mingjian He, SB
Thesis Topic: State-space Modeling of Neural Oscillations: Toward Assessing Alzheimer’s Disease Neuropathology with Sleep EEG
Brennan Leo Jackson, SB
Thesis Topic: The Impact of Gamma Stimulation on Neurological Phenotypes of Alzheimer's Dementia and Down Syndrome
Morgan Elizabeth Janes, SB
Thesis Topic: Engineering Translational Vaccine Delivery Systems with the Polyphenol Tannic Acid
Ashwin Srinivasan Kumar, BNG
Thesis Topic: Targeting B Cells to Improve Therapeutic Outcomes for Pediatric Medulloblastoma
Christian Landeros, SB
Thesis Topic: Machine-Guided Biopsy Analysis in Oncology: Facilitating Diagnostic Access and Biomedical Discovery Through Deep Learning
Ben D. Leaker, BNG
Thesis Topic: Biological and Biomechanical Effects of Direct Perturbation of Tissue Structure in the Cirrhotic Liver
Fiona Macleod, BNG
Thesis Topic: Investigating the Fidelity of Classic Cardiovascular Metrics in the Context of a Failing and Mechanically Supported Heart
Maria Carmen Martin Alonso, MNG
Thesis Topic: Amplifying Signals in the Tumor Microenvironment for Drug Development and Diagnostics
Eli Mattingly, SB
Thesis Topic: Design, Construction, and Validation of Magnetic Particle Imaging Systems for Rodent, Primate, and Human Functional Neuroimaging
Vincent Miao, BNG
Thesis Topic: Profiling Host Respiratory Responses to SARS-CoV-2 Infection
Allison Paige Porter, SB
Thesis Topic: Automation Framework for Exploration Medicine (AFEM): A Path for Integrating Automation into Autonomous Emergency Care
Rumya Raghavan, SB
Thesis Topic: Engineering Minimally Immunogenic Cargos and Delivery Modalities for Gene Therapy
Michelle Ramseier, SB
Thesis Topic: Cooptation of B Cell Developmental States in Malignancy and Autoimmunity
Luca Rosalia, MNG
Thesis Topic: Soft Robotic Platforms for the Simulation of Cardiovascular Disease and Device Development
Daphne Schlesinger, SB
Thesis Topic: Physiology-Inspired Deep Learning for Improved Heart Failure Management
Sydney Sherman, SB
Thesis Topic: Single-sided Magnetic Resonance Sensors for Clinical Detection of Volume Status
Nalini Singh, SB
Thesis Topic: Physics-Inspired Deep Learning for Inverse Problems in MRI
Anubhav Sinha, SB, MNG
Thesis Topic: Spatially Precise in situ Transcriptomics in Intact Biological Systems
Mingyu Yang, SB
Thesis Topic: Myelination Diseases of the Central Nervous System: Artificial Axons as in Vitro Models of Chemomechanical Cues
Master of Science
Health Sciences and Technology
Noah Stanley Warner, SB
Thesis Topic: A Framework for Detection and Observation of Radiation Chemistry Species on an MR-Linac
Certificate
Graduate Education in Medical Sciences
Akshay Kothakonda, BNG, SM
Thesis Topic: Engineering Mechanical Counter Pressure Spacesuits and Compression Garments: Active Pressurization and Design for Mobility
IMAGES
VIDEO
COMMENTS
computational approaches for transcription factor specificity engineering to expand the breadth of potential biosensor applications, and creating chimeric transcription factors to expedite biosensor discovery and overcome the currently high levels of characterization typically required to develop biosensors.
1. Introduction. Transcription is a crucial component of the central dogma of molecular biology (DNA-RNA-protein) [], serving as a bridge that translates genetic information into diverse forms at the individual level.Transcription factors (TFs) play a pivotal role in regulating the transcription of target genes by selectively recognizing and binding specific DNA regions known as TF binding ...
Transcription factors are proteins that initiate and modulate transcription rate by interacting with specific DNA recognition sequences in the target genes. As shown in Fig. 1, these DNA-binding transcription factors are structurally classified into four major classes: Helix-turn-helix homeodomain (e.g. PBX1 ), C. 2. H. 2 . zinc
Investigating the role of transcription factor, Trl, during germline development in the Drosophila ovary by Lindsay L. Davenport July 2019 Director of Thesis: Elizabeth T. Ables, Ph. D. Major Department: Biology Oogenesis is the process by which an egg develops from undifferentiated cells in the ovary.
scription factors. In this thesis, we focus on the binding of transcription factors to upstream region motifs to understand the mechanism of gene regulation. Sonic hedgehog (Shh) signals direct digit number and identity in the vertebrate limb via Gli transcription factors. We sought to identify key Gli binding motifs in
Introduction. The sine oculis (SIX) homeobox family of transcription factors play important developmental roles in a wide range of species from fruit flies to humans. The founding member, sine oculis (so), was first identified in Drosophila melanogaster where it was discovered to be required for compound eye formation (Cheyette et al., 1994; Serikaku and O'Tousa, 1994).
PREDICTING TRANSCRIPTION FACTOR BINDING USING NEURAL STRUCTURED LEARNING A Thesis in Bioinformatics and Genomics by Natalie Zesati Submitted in Partial Fulfillment of the Requirements for the Degree of Master of Science December 2020. ii The thesis of Natalie Zesati was reviewed and approved by the following: Shaun Mahony Assistant Professor of ...
I have also applied supervised learning methods for predicting transcription factor binding locations based on combinations of regulatory motifs. For each experiment in a compendium of ChIP-chip studies, I constructed a classifier to distinguish between regions bound by the given factor and regions bound by any other factor. For each
Transcription factors (TFs) transcriptionally regulate genes by binding nearby sequence elements. The evolutionary mechanisms driving the evolution of TF binding events between species are unclear. This thesis addresses three disparate predictions of natural selection acting on different
Transcription factors (TFs) recognize specific DNA sequences to control chromatin and transcription, forming a complex system that guides expression of the genome. Despite keen interest in understanding how TFs control gene expression, it remains challenging to determine how the precise genomic binding sites of TFs are specified and how TF ...
Background: Transcriptional factors (TFs) are responsible for regulating the transcription of pro-oncogenes and tumor suppressor genes in the process of tumor development. However, the role of these transcription factors in Bladder cancer (BCa) remains unclear. And the main purpose of this research is to explore the possibility of these TFs serving as biomarkers for BCa.
Thesis proposal Functional Validation of Transcription Factor to Gene Interactions by Statistical Learning of Gaussian Bayesian networks from SNP and Expression data. Jing Xiang Machine Learning Department Carnegie Mellon University [email protected] Committee members: Seyoung Kim Geoff Gordon Carl Kingsford Steffi Oesterreich January 23, 2017
This thesis explores the role of transcription factors in sensory neuron specification. We describe the transcription factor Foxs1 as an early sensory neuronal marker and use it to
Hinojosa, Leetoria, Investigating the Localization of FOXO Transcription Factors in. Glioblastoma. Master of Sciences (MS), May, 2020, 32pp., 1 table, 7 figures, 17 references. The Phosphatidylinositol 3 Kinase (PI3K) pathway is an essential intracellular signaling. pathway that regulates cellular growth, survival, and fate.
Transcription Factors. Transcription factors are proteins that bind to DNA-regulatory sequences (enhancers and silencers), usually localized in the 5 -upstream region of target genes, to modulate the rate of gene transcription. This may result in increased or decreased gene transcription, protein synthesis, and subsequent altered cellular function.
Illustration of an activator. In molecular biology, a transcription factor (TF) (or sequence-specific DNA-binding factor) is a protein that controls the rate of transcription of genetic information from DNA to messenger RNA, by binding to a specific DNA sequence. The function of TFs is to regulate—turn on and off—genes in order to make sure that they are expressed in the desired cells at ...
Transcription factors are proteins that help turn specific genes "on" or "off" by binding to nearby DNA. Transcription factors that are activators boost a gene's transcription. Repressors decrease transcription. Groups of transcription factor binding sites called enhancers and silencers can turn a gene on/off in specific parts of the body.
a Summary statistics of transcription factor (TF)-target gene(TG) links. b Peak annotation. c137 Distributions of number of co-binding TF), TGs, and peaks for individual transcription factors. 138 d Correlations between the numbers of co-binding transcription factors and target genes and the numbers 139 of co-binding TFs and the number of peaks.
Fullscreen. Transcription factor binding sites identification using machine learning techniques. Cite. Download(3.41 MB) Embed. thesis. posted on2023-01-18, 15:54authored byHai Thanh Do. Submission note: A thesis submitted in total fulfilment of the requirements for the degree of Doctor of Philosophy to the Department of Computer Science and ...
Here, we isolated and functionally characterized SmERF1L1, a novel JA (Jasmonic acid)-responsive gene encoding AP2/ERF transcription factor, from Salvia miltiorrhiza. SmERF1L1 was responsive to methyl jasmonate (MJ), yeast extraction (YE), salicylic acid (SA) and ethylene treatments. Subcellular localization assay indicated that SmERF1L1 ...
The plant-specific YABBY transcription factor family plays important roles in plant growth and development, particularly leaf growth, floral organ formation, and secondary metabolite synthesis. Here, we identified a total of 13 OfYABBY genes from the Osmanthus fragrans genome. These 13 OfYABBY genes were divided into five subfamilies through phylogenetic analysis, and genes in the same ...
We have investigated the contact points of a positive transcription factor with the internal control region of the 5S ribosomal RNA genes of Xenopus. The methylation of any one of eight G residues clustered at the 3′ end of the internal control region on the noncoding strand of the DNA or the ethylation of their surrounding phosphates interferes with the binding of this protein.
1. Introduction. Transcription factors (TFs) are a group of mediators that bind the promoter or regulatory sequence of a gene to control its rate of transcribing genetic information from DNA to messenger RNA ().This transcription control is key to ensuring an adequate level of expression of a given protein in targeted cells at a particular developmental stage.
A high-quality single-cell chromatin accessibility atlas of colorectal cancer epithelial cells identified two epigenetic subgroups that match intrinsic-consensus molecular subtypes along with key transcription factors and their synergistic modules that regulate subtype-specific phenotypic features.
The mitochondrial transcription factor A, TFAM, has a dual function in the organelle: it activates mitochondrial DNA transcription by binding to the HSP and LSP promoters, while in higher concentrations compacts the mtDNA. In this thesis the mechanism of complex formation between the mitochondrial transcription factor A
The binding of CaHDZ15 to the promoter of CaHSFA6a and thus the transcription of CaHSFA6a were enhanced by the presence of CaHsp70-2 , indicating that CaHsp70-2 contributes to thermotolerance at least partially by acting as a transcriptional coactivator for CaHDZ15 to activate the transcription of CaHSFA6a, similar to HSP70-14 which interacts ...
TRANSCRIPTION FACTOR BINDING SITES By LIANG ZHAO Bachelor of Science Zhejiang University Hangzhou, China 1992 . . Master of Engineering BetJmg Research Institute of Chemical Industry Beijing, China 1995 Submitted to the Faculty of the Graduate College of the Oklahoma State University in partial fulfillment of the requirements for the degree of
Bri1-EMS Suppressor 1 (BES1) and Brassinazole Resistant 1 (BZR1) are two key transcription factors in the brassinosteroid (BR) signaling pathway, serving as crucial integrators that connect various signaling pathways in plants. Extensive genetic and biochemical studies have revealed that BES1 and BZR1, along with other protein factors, form a complex interaction network that governs plant ...
Moreover, we investigated the nuclear entry and exit behaviors of the transcription factor Msn2 in yeast in response to heat stress (37°C) with different heating modes. The feasibility of this temperature-controlled platform for studying the protein dynamic behavior of yeast cells was demonstrated.
Thesis Topic: Structure-Based Network Analysis Predicts Pathogenic Variants in Human Proteins Associated with Inherited Retinal Disease. Sofia Hu, BA, PhD. Thesis Topic: Transcription Factor Antagonism Regulates Heterogeneity in Embryonic Stem Cell States. Nauman Javed, BS, PhD